Financial News
Articles published by Glaukos Corporation
Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21
January 31, 2024
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
December 20, 2023
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos Announces Participation in Stifel Healthcare Conference
November 07, 2023
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos Announces Third Quarter 2023 Financial Results
November 01, 2023
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023
October 11, 2023
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos Announces Second Quarter 2023 Financial Results
August 02, 2023
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023
July 12, 2023
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos Submits New Drug Application to U.S. FDA for iDose TR
February 27, 2023
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos Announces Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos Announces Participation in the Citi Healthcare Conference
February 15, 2023
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos to Release Fourth Quarter and Full Year 2022 Financial Results after Market Close on February 22
February 01, 2023
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Glaukos Announces Positive Results for iDose TR Exchange Trial, Highlighting Favorable Safety and Tolerability
January 10, 2023
From Glaukos Corporation
Via Business Wire
Tickers
GKOS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.